Report overview
This report contains market size and forecasts of Autologous Biologics in global, including the following market information:
Global Autologous Biologics Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Autologous Biologics Market Sales, 2018-2023, 2023-2030, (Kg)
Global top five Autologous Biologics companies in 2022 (%)
The global Autologous Biologics market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Adipose Tissue Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autologous Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Biologics Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, by Type, 2022 (%)
Adipose Tissue
Plasma
Others
Global Autologous Biologics Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Centers
Research Centers
Global Autologous Biologics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Autologous Biologics revenues share in global market, 2022 (%)
Key companies Autologous Biologics sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Autologous Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
